Log In
BCIQ
Print this Print this
 

CD20

  Manage Alerts
Collapse Summary General Information
Company Gliknik Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLymphoma
Indication DetailsTreat refractory lymphoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today